<VariationArchive VariationID="418466" VariationName="NM_002968.3(SALL1):c.3414_3415del (p.Cys1139fs)" VariationType="Deletion" Accession="VCV000418466" Version="13" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-07-23" DateCreated="2017-04-27" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="409645" VariationID="418466">
      <GeneList>
        <Gene Symbol="SALL1" FullName="spalt like transcription factor 1" GeneID="6299" HGNC_ID="HGNC:10524" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q12.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="51135982" stop="51152334" display_start="51135982" display_stop="51152334" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="51169885" stop="51185182" display_start="51169885" display_stop="51185182" Strand="-" />
          </Location>
          <OMIM>602218</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SALL1">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SALL1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_002968.3(SALL1):c.3414_3415del (p.Cys1139fs)</Name>
      <CanonicalSPDI>NC_000016.10:51138806:AT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q12.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="51138807" stop="51138808" display_start="51138807" display_stop="51138808" variantLength="2" positionVCF="51138806" referenceAlleleVCF="CAT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="51172718" stop="51172719" display_start="51172718" display_stop="51172719" variantLength="2" positionVCF="51172717" referenceAlleleVCF="CAT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>C1042fs</ProteinChange>
      <ProteinChange>C1139fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.51138807_51138808del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.51138807_51138808del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.51172718_51172719del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.51172718_51172719del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007990.1" sequenceAccession="NG_007990" sequenceVersion="1" change="g.17465_17466del">
            <Expression>NG_007990.1:g.17465_17466del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127892.2" sequenceAccession="NM_001127892" sequenceVersion="2" change="c.3123_3124del">
            <Expression>NM_001127892.2:c.3123_3124del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121364.1" sequenceAccession="NP_001121364" sequenceVersion="1" change="p.Cys1042fs">
            <Expression>NP_001121364.1:p.Cys1042fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002968.3" sequenceAccession="NM_002968" sequenceVersion="3" change="c.3414_3415del" MANESelect="true">
            <Expression>NM_002968.3:c.3414_3415del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002959.2" sequenceAccession="NP_002959" sequenceVersion="2" change="p.Cys1139fs">
            <Expression>NP_002959.2:p.Cys1139fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_674" sequenceAccession="LRG_674">
            <Expression>LRG_674:g.17465_17466del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002968.2" sequenceAccession="NM_002968" sequenceVersion="2" change="c.3414_3415delAT">
            <Expression>NM_002968.2:c.3414_3415delAT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002968.2" sequenceAccession="NM_002968" sequenceVersion="2" change="c.3414_3415del">
            <Expression>NM_002968.2:c.3414_3415del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16620210" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="602218.0012" DB="OMIM" />
        <XRef Type="rs" ID="1064793257" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002968.3(SALL1):c.3414_3415del (p.Cys1139fs) AND Townes-Brocks syndrome 1" Accession="RCV000007863" Version="9">
        <ClassifiedConditionList TraitSetID="2021">
          <ClassifiedCondition DB="MedGen" ID="C4551481">Townes-Brocks syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-10-15" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_002968.3(SALL1):c.3414_3415del (p.Cys1139fs) AND not provided" Accession="RCV000486755" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_002968.3(SALL1):c.3414_3415del (p.Cys1139fs) AND Townes syndrome" Accession="RCV000526857" Version="6">
        <ClassifiedConditionList TraitSetID="39833">
          <ClassifiedCondition DB="MedGen" ID="C0265246">Townes syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-07-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-18" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2017-04-27" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16971658</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17221874</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18000979</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19429598</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23894113</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2021" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6067" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Renal-ear-anal-radial syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anus, imperforate, with hand, foot and ear anomalies</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deafness, sensorineural, with imperforate anus and hypoplastic thumbs</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DEAFNESS, SENSORINEURAL, WITH IMPERFORATE ANUS AND THUMB ANOMALIES</ElementValue>
                <XRef Type="MIM" ID="107480" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Townes-Brocks syndrome 1</ElementValue>
                <XRef ID="MONDO:0054581" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TBS1</ElementValue>
                <XRef Type="MIM" ID="107480" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">TBS</ElementValue>
                <XRef ID="GTR000528876" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Townes-Brocks syndrome (TBS) is characterized by the triad of imperforate anus (84%), dysplastic ears (87%; overfolded superior helices and preauricular tags; frequently associated with sensorineural and/or conductive hearing impairment [65%]), and thumb malformations (89%; triphalangeal thumbs, duplication of the thumb [preaxial polydactyly], and rarely hypoplasia of the thumbs). Renal impairment (42%), including end-stage renal disease (ESRD), may occur with or without structural abnormalities (mild malrotation, ectopia, horseshoe kidney, renal hypoplasia, polycystic kidneys, vesicoutereral reflux). Congenital heart disease occurs in 25%. Foot malformations (52%; flat feet, overlapping toes) and genitourinary malformations (36%) are common. Intellectual disability occurs in approximately 10% of individuals. Rare features include iris coloboma, Duane anomaly, Arnold-Chiari malformation type 1, and growth retardation.</Attribute>
                <XRef ID="NBK1445" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301618</ID>
                <ID Source="BookShelf">NBK1445</ID>
              </Citation>
              <XRef ID="857" DB="Orphanet" />
              <XRef ID="C4551481" DB="MedGen" />
              <XRef ID="MONDO:0054581" DB="MONDO" />
              <XRef Type="MIM" ID="107480" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="39833" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38154" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Townes syndrome</ElementValue>
                <XRef ID="Townes-Brocks+syndrome/7145" DB="Genetic Alliance" />
                <XRef ID="24750000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Townes-Brocks syndrome</ElementValue>
                <XRef ID="MONDO:0007142" DB="MONDO" />
                <XRef ID="857" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TBS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7784" />
                <XRef ID="7784" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="857" DB="Orphanet" />
              <XRef ID="C0265246" DB="MedGen" />
              <XRef ID="C536974" DB="MeSH" />
              <XRef ID="MONDO:0007142" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS107480" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="28068" SubmissionDate="2018-06-19" DateLastUpdated="2018-06-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="602218.0012_TOWNES-BROCKS SYNDROME" title="SALL1, 2-BP DEL, 3414AT_TOWNES-BROCKS SYNDROME" />
        <ClinVarAccession Accession="SCV000028068" DateUpdated="2018-06-22" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-12-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with Townes-Brocks syndrome (107480), Furniss et al. (2007) reported a heterozygous 2-bp deletion (3414delAT) in the SALL1 gene, resulting in a frameshift and premature termination. The patient had a relatively mild phenotype, with 1 limb affected by preaxial polydactyly and a triphalangeal thumb. The mutation was found to undergo nonsense-mediated decay, which the authors postulated may have accounted for the relatively mild phenotype by eliminating a possible dominant-negative effect. See also 602218.0011.</Attribute>
              <Citation>
                <ID Source="PubMed">18000979</ID>
              </Citation>
              <XRef DB="OMIM" ID="107480" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SALL1" />
          </GeneList>
          <Name>SALL1, 2-BP DEL, 3414AT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 3414AT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602218.0012" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">TOWNES-BROCKS SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5452357" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_002968.3:c.3414_3415del|OMIM:107480" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002796721" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002968.3:c.3414_3415del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="107480" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3963471" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="a644b330271c6fdeaff7ca3962323642990a91312dd1d90f59a78c1e6e9e9be2|OMIM:107480" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002019985" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002968.3:c.3414_3415del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="107480" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1223129" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="1955406|MedGen:C0265246" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000630911" DateUpdated="2024-02-20" DateCreated="2017-12-26" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16971658</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17221874</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18000979</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19429598</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23894113</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 418466). This premature translational stop signal has been observed in individual(s) with renal hypoplasia, congenital limb malformation, and Townes-Brocks syndrome (PMID: 16971658, 17221874, 18000979, 19429598, 23894113). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Cys1139Trpfs*35) in the SALL1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 186 amino acid(s) of the SALL1 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SALL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.51172718_51172719del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265246" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB3109251</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1100622" SubmissionDate="2024-07-17" DateLastUpdated="2024-07-23" DateCreated="2017-04-27">
        <ClinVarSubmissionID localKey="GDXSV:483661" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000565515" DateUpdated="2024-07-23" DateCreated="2017-04-27" Type="SCV" Version="5" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant in the C-terminus predicted to result in protein truncation, as the last 186 amino acids are lost and replaced with 34 incorrect amino acids (HGMD); Published functional studies demonstrate reduced levels of cDNA in fibroblasts as compared to wild type but similar levels when treated with an inhibitor of nonsense-mediated mRNA decay (NMD), suggesting that the variant transcript undergoes NMD (PMID: 18000979); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23894113, 16971658, 18000979, 17221874)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SALL1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:54508</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002968.2:c.3414_3415del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_204_20230726054202</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_313_20240717054204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3963471" TraitType="Disease" MappingType="XRef" MappingValue="107480" MappingRef="OMIM">
        <MedGen CUI="C4551481" Name="Townes-Brocks syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1223129" TraitType="Disease" MappingType="XRef" MappingValue="C0265246" MappingRef="MedGen">
        <MedGen CUI="C0265246" Name="Townes syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="28068" TraitType="Disease" MappingType="Name" MappingValue="TOWNES-BROCKS SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0265246" Name="Townes syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1100622" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5452357" TraitType="Disease" MappingType="XRef" MappingValue="107480" MappingRef="OMIM">
        <MedGen CUI="C4551481" Name="Townes-Brocks syndrome 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

